Literature DB >> 10988124

Volume and cellular content of normal pleural fluid in humans examined by pleural lavage.

M Noppen1, M De Waele, R Li, K V Gucht, J D'Haese, E Gerlo, W Vincken.   

Abstract

Currently, no reliable data are available on the volume or on the cellular content of pleural fluid in normal humans. In analogy with bronchoalveolar lavage (a technique enabling retrieval of small volumes of epithelial lining fluid from the lung), we developed a pleural lavage (PL) technique consisting of injection and retrieval of 150 ml of saline into the right pleural space, performed during a thoracoscopic sympathicolysis procedure in otherwise healthy subjects suffering from essential hyperhidrosis. With urea used as an endogenous marker of dilution, measured mean right-sided pleural fluid volume was 8.4 +/- 4.3 ml. In a subgroup of subjects, we confirmed that right- and left-sided pleural fluid volumes were similar. Expressed per kilogram of body mass, total pleural fluid volume in normal, nonsmoking humans is 0.26 +/- 0.1 ml/kg. Total cell count in the PL fluid of nonsmoking normal subjects yielded a median of 91 x 10(3) white blood cells (WBC) per milliliter of lavage fluid (interquartile range [IR] = 124 x 10(3) cells/ml). Taking into account a measured dilution factor of 18.86, the total WBC count in the original pleural fluid was 1,716 x 10(3) cells/ml. Differential cell counts yielded a predominance of macrophages (median: 75%; IR: 16%) and lymphocytes (median: 23%; IR: 18%). Mesothelial cells (median: 1%; IR: 2%), neutrophils (median: 0%; IR: 1%), and eosinophils (median: 0%; IR: 0%) were only marginally present. There were no significant differences between males and females or between right- and left-sided pleural fluid in total and differential cell counts. In contrast, in smokers a small but statistically significant increase in pleural fluid neutrophils (median: 1%; IR: 2%; p < 0.015) was observed. In conclusion, PL performed during thoracoscopy for sympathicolysis allowed for the first time determination of the volume and of the total and differential cell contents of the pleural fluid present in normal human pleura.

Entities:  

Mesh:

Year:  2000        PMID: 10988124     DOI: 10.1164/ajrccm.162.3.9910050

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  24 in total

Review 1.  The anatomical and cellular basis of immune surveillance in the central nervous system.

Authors:  Richard M Ransohoff; Britta Engelhardt
Journal:  Nat Rev Immunol       Date:  2012-08-20       Impact factor: 53.106

2.  Differences in surfactant lipids collected from pleural and pulmonary lining fluids.

Authors:  Paul C Mills; Yi Chen; Yvette C Hills; Brian A Hills
Journal:  Pharm Res       Date:  2005-08-19       Impact factor: 4.200

3.  Inflammatory cytokines mediate C-C (monocyte chemotactic protein 1) and C-X-C (interleukin 8) chemokine expression in human pleural fibroblasts.

Authors:  Farzad Loghmani; Kamal A Mohammed; Najmunnisa Nasreen; Robert D Van Horn; Joyce A Hardwick; Kerry L Sanders; Veena B Antony
Journal:  Inflammation       Date:  2002-04       Impact factor: 4.092

4.  Determining optimal fluid and air leak cut off values for chest drain management in general thoracic surgery.

Authors:  Miguel Mesa-Guzman; Perikleous Periklis; Zakiyah Niwaz; Laura Socci; Hilgardt Raubenheimer; Ben Adams; Lokesh Gurung; Mohsin Uzzaman; Eric Lim
Journal:  J Thorac Dis       Date:  2015-11       Impact factor: 2.895

5.  Elevated expression of prostaglandin receptor and increased release of prostaglandin E2 maintain the survival of CD45RO+ T cells in the inflamed human pleural space.

Authors:  Elisabetta Pace; Tony F Bruno; Byron Berenger; Christopher H Mody; Mario Melis; Maria Ferraro; Annalisa Tipa; Andreina Bruno; Mirella Profita; Giovanni Bonsignore; Mark Gjomarkaj
Journal:  Immunology       Date:  2007-04-26       Impact factor: 7.397

Review 6.  Malignant pleural effusion: tumor-host interactions unleashed.

Authors:  Georgios T Stathopoulos; Ioannis Kalomenidis
Journal:  Am J Respir Crit Care Med       Date:  2012-05-31       Impact factor: 21.405

7.  Intrapleural Gene Therapy for Alpha-1 Antitrypsin Deficiency-Related Lung Disease.

Authors:  Katie M Stiles; Dolan Sondhi; Stephen M Kaminsky; Bishnu P De; Jonathan B Rosenberg; Ronald G Crystal
Journal:  Chronic Obstr Pulm Dis       Date:  2018-08-17

Review 8.  Gene Therapy for Alpha-1 Antitrypsin Deficiency Lung Disease.

Authors:  Maria J Chiuchiolo; Ronald G Crystal
Journal:  Ann Am Thorac Soc       Date:  2016-08

9.  Effects of coexisting pneumonia and end-stage renal disease on pleural fluid analysis in patients with hydrostatic pleural effusion.

Authors:  Peter Doelken; John T Huggins; Mark Goldblatt; Paul Nietert; Steven A Sahn
Journal:  Chest       Date:  2013-06       Impact factor: 9.410

Review 10.  The treatment of pleural carcinosis with malignant pleural effusion.

Authors:  Michael Ried; Hans-Stefan Hofmann
Journal:  Dtsch Arztebl Int       Date:  2013-05       Impact factor: 5.594

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.